A prospective single centre single arm open label study of the long term use of a LHRH agonist (Decapeptyl SR 11.25mg) in combination with livial add-back therapy in the management of chronic cyclical pelvic pain in pre-menopausal women

Trial Profile

A prospective single centre single arm open label study of the long term use of a LHRH agonist (Decapeptyl SR 11.25mg) in combination with livial add-back therapy in the management of chronic cyclical pelvic pain in pre-menopausal women

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Jul 2016

At a glance

  • Drugs Triptorelin (Primary) ; Tibolone
  • Indications Pelvic pain
  • Focus Therapeutic Use
  • Sponsors Ipsen
  • Most Recent Events

    • 01 Jul 2016 Status changed from active, no longer recruiting to completed.
    • 27 Feb 2015 Status changed from recruiting to active, no longer recruiting according to the United Kingdom Clinical Research Network record.
    • 25 Jan 2014 Accrual to date is 77% according to United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top